Honolulu, October 2026 The neurologists, epileptologists and research team of Hawaii’s Comprehensive Epilepsy Center & Epilepsy Research Unit. The Hawaii Comprehensive Epilepsy Center and Epilepsy Research Unit have been awarded a new Phase 3 study investigating JZP926 (CBD oral solution,…
Edit Content